Viewpoint: The Human Capital Approach to Inference
暂无分享,去创建一个
[1] P. Bech,et al. Escitalopram dose-response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression. , 2004, The international journal of neuropsychopharmacology.
[2] K. Popper,et al. Conjectures and refutations;: The growth of scientific knowledge , 1972 .
[3] U. Lepola,et al. Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo‐controlled study in depression in primary care , 2003, International clinical psychopharmacology.
[4] R. Findling,et al. A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.
[5] Rajeev Dehejia,et al. Program Evaluation as a Decision Problem , 1999 .
[6] P. Kuhn,et al. Lab Labor: What Can Labor Economists Learn from the Lab? , 2010, SSRN Electronic Journal.
[7] G. Imbens,et al. Efficient Estimation of Average Treatment Effects Using the Estimated Propensity Score , 2000 .
[8] K. Popper,et al. Conjectures and refutations;: The growth of scientific knowledge , 1972 .
[9] Huaiyu Yang,et al. Rating Scales for Depression , 2009 .
[10] J. Mendels,et al. Sertraline safety and efficacy in major depression: A double-blind fixed-dose comparison with placebo , 1995, Biological Psychiatry.
[11] D. Hamermesh. Six Decades of Top Economics Publishing: Who and How? , 2012 .
[12] Ching Y. Suen,et al. Historical review of OCR research and development , 1992, Proc. IEEE.
[13] S. Stahl. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline , 2000, Biological Psychiatry.
[14] E. Armstrong,et al. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial* , 2007, Current medical research and opinion.
[15] Joshua D. Angrist,et al. Identification of Causal Effects Using Instrumental Variables , 1993 .
[16] James J Heckman,et al. Building Bridges between Structural and Program Evaluation Approaches to Evaluating Policy , 2010, Journal of economic literature.
[17] M. Rehavi,et al. Physicians Treating Physicians: Information and Incentives in Childbirth , 2013 .
[18] M. Dickstein. Physician vs. Patient Incentives in Prescription Drug Choice , 2014 .
[19] Alexander C. McLain,et al. Multiple Testing of Composite Null Hypotheses in Heteroscedastic Models , 2012 .
[20] R. Findling,et al. Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial. , 2013, Journal of child and adolescent psychopharmacology.
[21] F. Yates. The analysis of replicated experiments when the field results are incomplete , 1933 .
[22] G. Arbanas. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) , 2015 .
[23] M. Rynn,et al. Sertraline in children and adolescents with major depressive disorder. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.
[24] Stuart R Lipsitz,et al. Relationship Between Cesarean Delivery Rate and Maternal and Neonatal Mortality. , 2015, JAMA.
[25] G. Emslie,et al. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.
[26] J. I. The Design of Experiments , 1936, Nature.
[27] G. Imbens,et al. Machine Learning Methods for Estimating Heterogeneous Causal Eects , 2015 .
[28] E. Vytlacil. Independence, Monotonicity, and Latent Index Models: An Equivalence Result , 2002 .
[29] M. Owings,et al. Physician Financial Incentives and Cesarean Section Delivery , 1994, The Rand journal of economics.
[30] E. Cook,et al. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. , 1998, JAMA.
[31] László Györfi,et al. A Probabilistic Theory of Pattern Recognition , 1996, Stochastic Modelling and Applied Probability.
[32] Jeffrey A. Smith,et al. Does Matching Overcome Lalonde's Critique of Nonexperimental Estimators? , 2000 .
[33] J. Skinner,et al. DIAGNOSIS AND UNNECESSARY PROCEDURE USE: EVIDENCE FROM C-SECTION , 2013 .
[34] P. Llorca,et al. Efficacy of escitalopram in patients with severe depression: a pooled analysis , 2005, International journal of clinical practice.
[35] Alan Manning,et al. The Credibility Revolution in Empirical Economics: How Better Research Design is Taking the Con Out of Econometrics , 2010, SSRN Electronic Journal.
[36] W. MacLeod,et al. Provider practice style and patient health outcomes: The case of heart attacks. , 2016, Journal of health economics.
[37] Joshua D. Angrist,et al. The Credibility Revolution in Empirical Economics: How Better Research Design is Taking the Con Out of Econometrics , 2010, SSRN Electronic Journal.
[38] C. Porter,et al. Mysteries and Conspiracies: Detective Stories, Spy Novels and the Making of Modern Societies , 2014 .
[39] Bo E. Honoré,et al. The Empirical Content of the Roy Model , 1990 .
[40] Imran Rasul,et al. Field Experiments in Labor Economics , 2010 .
[41] Lee Baer,et al. Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health , 2010, Current Clinical Psychiatry.
[42] D. Freedman. Statistical Models for Causation , 2006, Evaluation review.
[43] J. Angrist,et al. Empirical Strategies in Labor Economics , 1998 .
[44] U. Lepola,et al. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care , 2002, International clinical psychopharmacology.
[45] Eric R. Ziegel,et al. The Elements of Statistical Learning , 2003, Technometrics.
[46] Julie Bynum,et al. Regional variations in diagnostic practices. , 2010, The New England journal of medicine.
[47] P. Cuijpers,et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis , 2016, The Lancet.
[48] A. Roy. Some thoughts on the distribution of earnings , 1951 .
[49] P. Llorca,et al. Traitement des épisodes dépressifs sévères : escitalopram est plus efficace que citalopram , 2004 .
[50] P. Holland. Statistics and Causal Inference , 1985 .
[51] A. Epstein,et al. The Formation and Evolution of Physician Treatment Styles: An Application to Cesarean Sections , 2005, Journal of health economics.
[52] W. MacLeod,et al. Physician Practice Style and Patient Health Outcomes: The Case of Heart Attacks , 2015 .
[53] B. Shepherd,et al. GUIDO IMBENS, DONALD RUBIN, Causal Inference for Statistics, Social, and Biomedical Sciences: An Introduction. New York: Cambridge University Press. , 2016, Biometrics.
[54] John C. Ham,et al. Special issue on Experimental and non-experimental evaluation of economic policy and models , 2005 .
[55] Han Bleichrodt,et al. Handbook of Health Economics , 2001 .
[56] D. Rubin,et al. The central role of the propensity score in observational studies for causal effects , 1983 .
[57] Abhijit Banerjee,et al. The Experimental Approach to Development Economics , 2008 .
[58] Jiaying Gu,et al. Oracle and Adaptive False Discovery Rate Controlling Methods for One�?Sided Testing: Theory and Application in Treatment Effect Evaluation , 2018 .
[59] D. Kahneman,et al. Conditions for intuitive expertise: a failure to disagree. , 2009, The American psychologist.
[60] W. MacLeod,et al. First Do No Harm?: Tort Reform and Birth Outcomes , 2006 .
[61] M. Knapp,et al. Economics and mental health , 1994 .
[62] U. Lepola,et al. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care. , 2003 .
[63] Heidi L. Williams,et al. Sources of Geographic Variation in Health Care: Evidence from Patient Migration , 2014, The quarterly journal of economics.
[64] Amitabh Chandra,et al. Who Ordered That? The Economics of Treatment Choices in Medical Care , 2011 .
[65] James J. Heckman,et al. Assessing the Case for Social Experiments , 1995 .
[66] Marvin C. Alkin,et al. What Have We Learned? , 2019, Stumbling Blocks Against Unification.
[67] Angus Deaton. Instruments, Randomization, and Learning about Development , 2010 .
[68] T. Mcguire,et al. Chapter 16 Economics and mental health , 2000 .
[69] P. Mahalanobis. On large-scale sample surveys , 1944, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences.
[70] W. Burke,et al. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. , 2002, The Journal of clinical psychiatry.
[71] Amitabh Chandra,et al. Productivity Spillovers in Health Care: Evidence from the Treatment of Heart Attacks , 2007, Journal of Political Economy.
[72] M. Rynn,et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. , 2003, JAMA.
[73] K. Krishnan,et al. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. , 2003, The American journal of psychiatry.
[74] L. Arnold,et al. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder* , 2007, Current medical research and opinion.
[75] E. Katz,et al. A double-blind placebo-controlled multicentre study of sertraline in the acute and continuation treatment of major depression , 1997, European Psychiatry.